15-deoxy-Δ12,14-prostaglandin J2 inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome proliferator-activated receptor-γ and heme oxygenase-1 in rat hippocampal slices

Journal of Neuroscience Research

Volumn 90, Issue 9, 2012, Pages 1732-1742

  Kim, Sang Eun ^a   Lee, Eun Ok ^a   Yang, Ji Hye ^a   Kang, Ji Hee Lee ^a   Suh, Yoo Hun ^b   Chong, Young Hae ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

15d PGJ2; Hippocampus; HIV 1 Tat; HO 1; NADPH oxidase

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; APOCYNIN; HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTOPORPHYRIN COBALT; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROGLIA; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CHEMOKINE CCL2; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEME OXYGENASE-1; HIPPOCAMPUS; HIV-1; HUMANS; MAP KINASE SIGNALING SYSTEM; MICROGLIA; PPAR GAMMA; PROSTAGLANDIN D2; RATS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84863776881     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23051     Document Type: Article

References (59)

1. Aksenov MY, Aksenova MV, Nath A, Ray PD, Mactutus CF, Booze RM. 2006. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27: 217-228.
2. Aksenova MV, Aksenov MY, Adams SM, Mactutus CF, Booze RM. 2009. Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Exp Neurol 215: 253-263.
3. Alvarez-Maqueda M, El Bekay R, Alba G, Monteseirín J, Chacón P, Vega A, Martín-Nieto J, Bedoya FJ, Pintado E, Sobrino F. 2004. 15-Deoxy-Δ12, 14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. J Biol Chem 279: 21929-21937.
4. Appel S, Mirakaj V, Bringmann A, Weck MM, Grünebach F, Brossart P. 2005. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 106: 3888-3894.
5. Brailoiu GC, Brailoiu E, Chang JK, Dun NJ. 2008. Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons. Neuroscience 151: 701-710.
6. Brana C, Biggs TE, Mann DA, Sundstrom LE. 1999. A macrophage hippocampal slice coculture system: application to the study of HIV-induced brain damage. J Neurosci Methods 90: 7-11.
7. Brousseau KM, Filley CM, Kaye K, Kiser JJ, Adler LE, Connick E. 2009. Dementia with features of Alzheimer's disease and HIV-associated dementia in an elderly man with AIDS. AIDS 23: 1029-1031.
8. Chana RS, Lewington AJ, Brunskill NJ. 2004. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists. Kidney Int 65: 2081-2090.
9. 12, 14-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292). Int Arch Allerg Immunol 149: 77-82.
10. Chong YH, Shin YJ, Suh YH. 2003. Cyclic AMP inhibition of tumor necrosis factor alpha production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages: involvement of multiple intracellular pathways and cyclic AMP response element binding protein. Mol Pharmacol 63: 690-698.
11. Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ. 2006. ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 281: 20315-20325.
12. D'Aversa TG, Eugenin EA, Berman JW. 2005. NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J Neurosci Res 81: 436-446.
13. Del Valle L, Croul S, Morgello S, Amini S, Rappaport J, Khalili K. 2000. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol 6: 221-228.
14. Dhikav V, Anand K. 2011. Potential predictors of hippocampal atrophy in Alzheimer's disease. Drugs Aging 28: 1-11.
15. Dhillon NK, Williams R, Callen S, Zien C, Narayan O, Buch S. 2008. Roles of MCP-1 in development of HIV-dementia. Front Biosci 13: 3913-3918.
16. El-Hage N, Wu G, Ambati J, Bruce-Keller AJ, Knapp PE, Hauser KF. 2006. CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. J Neuroimmunol 178: 9-16.
17. Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW. 2003. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 85: 1299-1311.
18. Firth CA, Yang YT, Gieseg SP. 2007. Lipid oxidation predominates over protein hydroperoxide formation in human monocyte-derived macrophages exposed to aqueous peroxyl radicals. Free Rad Res 41: 839-848.
19. Gannon P, Khan MZ, Kolson DL. 2011. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24: 275-283.
20. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
21. Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL. 2009. Inflammation and NF-kappaB in Alzheimer's disease and diabetes. J Alzheimers Dis 16: 809-821.
22. Gras G, Kaul M. 2010. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 7: 7-30.
23. Holopainen IE. 2005. Organotypic hippocampal slice cultures: a model system to study basic cellular and molecular mechanisms of neuronal cell death, neuroprotection, and synaptic plasticity. Neurochem Res 30: 1521-1528.
24. Irish BP, Khan ZK, Jain P, Nonnemacher MR, Pirrone V, Rahman S, Rajagopalan N, Suchitra JB, Mostoller K, Wigdahl B. 2009. Molecular mechanisms of neurodegenerative diseases induced by human retroviruses: a review. Am J Infect Dis 5: 231-258.
25. Jones A, Kulozik P, Ostertag A, Herzig S. 2009. Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes. J Alzheimers Dis 16: 787-808.
26. Kalantari P, Narayan V, Henderson AJ, Prabhu KS. 2009. 15-Deoxy-delta12, 14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification. FASEB J 23: 2366-2373.
27. 12, 14-prostaglandin J2. Free Rad Biol Med 7: 1310-1317.
28. Kaul M, Lipton SA. 2006. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4: 307-318.
29. Khiati A, Chaloin O, Muller S, Tardieu M, Horellou P. 2010. Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent. J Neurovirol 16: 150-167.
30. 12, 14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. Carcinogenesis 30: 645-654.
31. Kim EH, Na HK, Surh YJ. 2006. Upregulation of VEGF by 15-deoxy-delta12, 14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. Ann N Y Acad Sci 1090: 375-384.
32. Lee EO, Kang JL, Chong YH. 2005. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. J Biol Chem 280: 7845-7853.
33. Lee EO, Kim SE, Park HK, Kang JL, Chong YH. 2011. Extracellular HIV-1 Tat upregulates TNF-α dependent MCP-1/CCL2 production via activation of ERK1/2 pathway in rat hippocampal slice cultures: inhibition by resveratrol, a polyphenolic phytostilbene. Exp Neurol 229: 399-408.
34. Lee JH, Lee EO, Kang JL, Chong YH. 2008. Concomitant degradation of beta-catenin and GSK-3 beta potently contributes to glutamate-induced neurotoxicity in rat hippocampal slice cultures. J Neurochem 106: 1066-1077.
35. Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. 2010. Inflammation and Alzheimer's disease. Arch Pharm Res 33: 1539-1556.
36. Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL. 2002. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41: 6640-6650.
37. Lombardi A, Cantini G, Piscitelli E, Gelmini S, Francalanci M, Mello T, Ceni E, Varano G, Forti G, Rotondi M, Galli A, Serio M, Luconi M. 2008. A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells. Arterioscler Thromb Vasc Biol 28: 718-724.
38. Lombardi A, Cantini G, Mello T, Francalanci M, Gelmini S, Cosmi L, Santarlasci V, Degl'Innocenti S, Luciani P, Deledda C, Annunziato F, Forti G, Galli A, Serio M, Luconi M. 2009. Molecular mechanisms underlying the proinflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium. Eur J Cell Biol 88: 731-742.
39. Madrigal JL, Leza JC, Polak P, Kalinin S, Feinstein DL. 2009. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci 29: 263-267.
40. Morse D, Choi AM. 2005. Heme oxygenase-1 from bench to bedside. Am J Respir Crit Care Med 172: 660-670.
41. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, Haughey N, Geiger JD. 1996. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 70: 1475-1480.
42. Pae HO, Chung HT. 2009. Heme oxygenase-1: its therapeutic roles in inflammatory diseases. Immune Netw 9: 12-19.
43. Qin S, McLaughlin AP, De Vries GW. 2006. Protection of RPE cells from oxidative injury by 15-deoxy-delta12, 14-prostaglandin J2 by augmenting GSH and activating MAPK. Invest Ophthalmol Vis Sci 47: 5098-105.
44. Ragin AB, Wu Y, Ochs R, Scheidegger R, Cohen BA, Edelman RR, Epstein LG, McArthur J. 2010. Biomarkers of neurological status in HIV infection: a 3-year study. Proteomics Clin Appl 4: 295-303.
45. Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD. 2006. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 6: 246-254.
46. Romani B, Engelbrecht S, Glashoff RH. 2010. Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol 91: 1-12.
47. Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T. 2009. Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 32: 1626-1633.
48. Scher JU, Pillinger MH. 2009. The antiinflammatory effects of prostaglandins. J Invest Med 57: 703-708.
49. Schilling M, Strecker JK, Schäbitz WR, Ringelstein EB, Kiefer R. 2009. Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 161: 806-812.
50. 2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. Biochem Pharmacol 82: 1335-1351.
51. Tontonoz P, Spiegelman BM. 2008. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77: 289-312.
52. Turchan-Cholewo J, Dimayuga VM, Gupta S, Gorospe RM, Keller JN, Bruce-Keller AJ. 2009. NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat. Antiox Redox Signal 11: 193-204.
53. Valcour V, Sithinamsuwan P, Letendre S, Ances B. 2011. Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep 8: 54-61.
54. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG. 2005. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 13: 950-958.
55. Williams R, Yao H, Peng F, Yang Y, Bethel-Brown C, Buch S. 2010. Cooperative induction of CXCL10 involves NADPH oxidase: implications for HIV dementia. Glia 58: 611-621.
56. Wilmer WA, Dixon C, Lu L, Hilbelink T, Rovin BH. 2001. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARγ. Biochem Biophys Res Commun 281: 57-62.
57. Wright E. 2011. Neurocognitive impairment and neuroCART. Curr Opin HIV AIDS 6: 303-308.
58. Xu J, Ikezu T. 2009. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol 4: 200-212.
59. Zauli G, Gibellini D. 1996. The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression. Leuk Lymphoma 23: 551-560.